LCN1P1
Putative lipocalin 1-like protein 1
Also known as: LC1L1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for LCN1P1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
162 residues, UniProt reviewed canonical sequence.
>Q5VSP4|LCN1P1
1 MKPLLLAISL SLIAALQAHH LLASDEEIQD VSGTWYLKAM TVDRELPEMN LESVTPMTLT
61 ILEGGNLEAK ATMLISGQCQ EVKVILEKTD EPGKYTANRG KHVAYIIRSH MKDHYIFYCE
121 GRDPENNLEA LEDFEKAAGA RGLSTESILI PRQSETCSPG SDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LCN1P1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LCN1P1 as an antibody target. Whether an autoantibody or antibody against LCN1P1 could matter depends on whether native LCN1P1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LCN1P1 is annotated as secreted, so native LCN1P1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LCN1P1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...